Can You Master MASH Diagnosis and Management?

CME Jeopardy™

Turning the Tide on Eosinophilic Granulomatosis With Polyangiitis

New Targeted Strategies to Reduce

PBC Powerlifting

Optimizing Your Management Skills with New Treatment Tools

Primary Biliary Cholangitis

A High-Yield Guide to PBC Management in the Era of PPAR Agonists

Making the Call in Eosinophilic Esophagitis

New Strategies for Adult and Pediatric Patients

Comprehensive Case Challenges in MASH

Diagnosing, Staging, and Treating Patients in an Advancing Field

Top 10 Things You Need to Know in the New PBC Landscape

Tools to Optimize Patient Outcomes

Pan-Viral ACTIONS

A Call to Implement One-stop Screening

The Top 10 Pitfalls in Initiating Advanced Therapy in IBD

Tools to Optimize Patient Outcomes

Multi-Cancer Early Detection

Incorporating Blood-Based Screening Tools into Primary Care Practice

Staying Vigilant for Immunocompromised Patients

What’s Next

Exploring New Treatment Avenues in Nonadvanced Systemic Mastocytosis

Advances in Managing Fistulizing Crohn's Disease

A Multidisciplinary Approach

A Clinician’s Guide to HCV Treatment in the Primary Care Setting

Is It Systemic Mastocytosis?

Best Practices for Diagnosis and Management

Putting a Spotlight on Systemic Mastocytosis

A Multidisciplinary Look at Early Diagnosis and Management

Answering the Call

Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema

Finding the Path in Eosinophilic Esophagitis

Interdisciplinary Strategies for Adult and Pediatric Patients

Treating Hepatitis C in the Primary Care Setting

Establishing Clinical Readiness Through Mentored Learning

IBD Journal Club:

Volume 1: A Guided Tour of the Evidence Driving Selection of First-line Advanced Therapies in Moderate to Severe IBD

Hot Topics in HCV

A Multidisciplinary Online Mini-Curriculum

Optimizing Advanced Therapies in Ulcerative Colitis: Is Your Practice Up to Date?

A Focus on Clinical Evidence and Guideline Recommendations

Setting a Course for the Optimal Management of IBD

An Interactive Learning Experience

A Critical Appraisal of Non-Invasive Technologies in NASH

Informing the Future of NASH Diagnosis and Assessment

BRIDGE HCV

Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV

Stepping Up to the Challenge

The PCP’s Role in HCV Elimination

Trends and Updates in IBD

Appraising the Therapeutic Armamentarium in Moderate and Severe Disease